Geron Cellvein Successfully Hosts 'PRISM PDRN Seminar'... Presents Clinical Application Guide for 'Cellvein Injection'

From the left, Hyundong Jang, President of the Korean Society of Manual Medicine and Vice President of the Korean Neurosurgical Society (Representative Director of Hyun Hospital), Goeun Lee, Public Relations Director of the Korean Academy of Rehabilitation Medicine (Representative Director of Reset Rehabilitation Medicine), Sehwahn Choi, President of the Korean Society of Neuropathic Pain (Representative Director of Seoul St. Mary's Neurosurgery). Provided by Geroncel Bein

원본보기 아이콘

Geron Cellvein, a company specializing in the production of prescription pharmaceuticals, successfully hosted the 'PRISM PDRN Seminar,' sharing the latest research and clinical application insights.

On April 6, Geron Cellvein announced that approximately 100 medical professionals and related industry experts attended the seminar, which was held under the theme "The Functions of PDRN You Didn't Know Until Now." The event focused on the latest research trends on PDRN, as well as real-world clinical application cases.

The seminar featured lectures by Sehwann Choi, President of the Korean Society of Cerebrovascular Medicine (CEO of Seoul St. Mary's Neurosurgery), Goeun Lee, Public Relations Director of the Korean Academy of Rehabilitation Medicine (CEO of Reset Rehabilitation Medicine), and Hyundong Jang, President of the Korean Academy of Manual Medicine and Vice President of the Korean Neurosurgical Society (CEO of Current Hospital).

The lectures covered topics such as: ▲New functions of PDRN and various clinical applications of 'Cellvein Injection' ▲Latest insights into pain treatment using ultrasound-guided PDRN injections ▲Integrated treatment strategies utilizing 'Cellvein Injection.' These practical topics, applicable to real-world medical settings, garnered significant interest from attendees.

Notably, the event went beyond simple theoretical explanations, suggesting the potential for expanding PDRN's application areas not only to musculoskeletal pain treatment, but also to chronic disease management, aesthetic dermatology, and hair loss. This added both academic and industrial significance to the seminar.

Dukkyu Kim, CEO of Geron Cellvein, stated, "This seminar was a meaningful opportunity to share new perspectives and clinical possibilities for PDRN," and added, "We will continue to expand research and academic exchange based on regenerative medicine to provide practical solutions that benefit the medical field."

He further emphasized, "We will strengthen our evidence-based approach using real clinical data to offer trustworthy treatment options for healthcare professionals. We aim to secure a leading position in the field of regenerative medicine centered on PDRN."

Meanwhile, Geron Cellvein continues its research and development in the fields of tissue regeneration and inflammatory disease treatment based on regenerative medicine, and is accelerating its expansion into the global market through a range of academic activities.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.